This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Juergen Mueller, Ph.D.
Commercial and Strategic Development Director Oligo-therapeutics at LGC Axolabs


Juergen is currently Commercial Director NAT (Nucleic Acid Therapeutics) at LGC Axolabs, covering the commercial and sales responsibility for all clinical service programs in the Oligo-therapeutics field within LGC. This includes worldwide marketing & sales responsibity since LGC serves clients in EU, US (North America including Canada and South America), and APAC region. Juergen spend more than >20 years in the Life Science industry while having held senior management positions in BD, Sales and Marketing, Licensing and Project Management from Fortune 500 companies, such as Sigma-Aldrich (US), up to service providers as Solvias (CH), and leading Oligo CMO’s as Nitto-Avecia (US/Jpn). Drug development experience as CSO for Syndeco (CH) while developing small molecule and peptide NCE’s from lead to clinical candidates. Author and inventor of >40 peer reviewed scientific articles and patents.

Agenda Sessions

  • LGC’s Development of a Novel, Modular, GalNAc Cluster Access, and Conjugation Strategies for Nucleic Acid Medicines